156 related articles for article (PubMed ID: 33850265)
21. Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type.
VanMeter AJ; Rodriguez AS; Bowman ED; Jen J; Harris CC; Deng J; Calvert VS; Silvestri A; Fredolini C; Chandhoke V; Petricoin EF; Liotta LA; Espina V
Mol Cell Proteomics; 2008 Oct; 7(10):1902-24. PubMed ID: 18687633
[TBL] [Abstract][Full Text] [Related]
22. V843I, a lung cancer predisposing EGFR mutation, is responsible for resistance to EGFR tyrosine kinase inhibitors.
Matsushima S; Ohtsuka K; Ohnishi H; Fujiwara M; Nakamura H; Morii T; Kishino T; Goto H; Watanabe T
J Thorac Oncol; 2014 Sep; 9(9):1377-84. PubMed ID: 25057940
[TBL] [Abstract][Full Text] [Related]
23. The induction of MIG6 under hypoxic conditions is critical for dormancy in primary cultured lung cancer cells with activating EGFR mutations.
Endo H; Okami J; Okuyama H; Nishizawa Y; Imamura F; Inoue M
Oncogene; 2017 May; 36(20):2824-2834. PubMed ID: 27893711
[TBL] [Abstract][Full Text] [Related]
24. Diminished functional role and altered localization of SHP2 in non-small cell lung cancer cells with EGFR-activating mutations.
Furcht CM; Muñoz Rojas AR; Nihalani D; Lazzara MJ
Oncogene; 2013 May; 32(18):2346-55, 2355.e1-10. PubMed ID: 22777356
[TBL] [Abstract][Full Text] [Related]
25. The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants.
Chung BM; Dimri M; George M; Reddi AL; Chen G; Band V; Band H
Oncogene; 2009 Apr; 28(16):1821-32. PubMed ID: 19305428
[TBL] [Abstract][Full Text] [Related]
26. Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells.
Hsu A; Zhang W; Lee JF; An J; Ekambaram P; Liu J; Honn KV; Klinge CM; Lee MJ
Int J Oncol; 2012 May; 40(5):1619-26. PubMed ID: 22344462
[TBL] [Abstract][Full Text] [Related]
27. Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.
Yoshida T; Ishii G; Goto K; Neri S; Hashimoto H; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Iida S; Niimi A; Nagai K; Ohe Y; Ochiai A
Clin Cancer Res; 2015 Feb; 21(3):642-51. PubMed ID: 25388165
[TBL] [Abstract][Full Text] [Related]
28. Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma.
Zhou X; Guo J; Ji Y; Pan G; Liu T; Zhu H; Zhao J
Mol Cancer Res; 2016 May; 14(5):448-57. PubMed ID: 26896556
[TBL] [Abstract][Full Text] [Related]
29. Survival outcome assessed according to tumor burden and progression patterns in patients with epidermal growth factor receptor mutant lung adenocarcinoma undergoing epidermal growth factor receptor tyrosine kinase inhibitor therapy.
Cha YK; Lee HY; Ahn MJ; Choi YL; Lee JH; Park K; Lee KS
Clin Lung Cancer; 2015 May; 16(3):228-36. PubMed ID: 25499173
[TBL] [Abstract][Full Text] [Related]
30. p14(ARF) inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway.
Ozenne P; Dayde D; Brambilla E; Eymin B; Gazzeri S
Oncogene; 2013 Feb; 32(8):1050-8. PubMed ID: 22450744
[TBL] [Abstract][Full Text] [Related]
31. ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling.
Li X; Huang Y; Jiang J; Frank SJ
Cell Signal; 2008 Nov; 20(11):2145-55. PubMed ID: 18762250
[TBL] [Abstract][Full Text] [Related]
32. Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor-tyrosine kinase inhibitors.
Chang HC; Chen YM; Tseng CC; Huang KT; Wang CC; Chen YC; Lai CH; Fang WF; Kao HC; Lin MC
Tumour Biol; 2017 Mar; 39(3):1010428317695939. PubMed ID: 28351317
[TBL] [Abstract][Full Text] [Related]
33. Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.
Akca H; Tani M; Hishida T; Matsumoto S; Yokota J
Lung Cancer; 2006 Oct; 54(1):25-33. PubMed ID: 16872715
[TBL] [Abstract][Full Text] [Related]
34. Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src.
Chung BM; Raja SM; Clubb RJ; Tu C; George M; Band V; Band H
BMC Cell Biol; 2009 Nov; 10():84. PubMed ID: 19948031
[TBL] [Abstract][Full Text] [Related]
35. Isoliquiritigenin induces apoptosis and inhibits xenograft tumor growth of human lung cancer cells by targeting both wild type and L858R/T790M mutant EGFR.
Jung SK; Lee MH; Lim DY; Kim JE; Singh P; Lee SY; Jeong CH; Lim TG; Chen H; Chi YI; Kundu JK; Lee NH; Lee CC; Cho YY; Bode AM; Lee KW; Dong Z
J Biol Chem; 2014 Dec; 289(52):35839-48. PubMed ID: 25368326
[TBL] [Abstract][Full Text] [Related]
36. Tid1-L inhibits EGFR signaling in lung adenocarcinoma by enhancing EGFR Ubiquitinylation and degradation.
Chen CY; Jan CI; Lo JF; Yang SC; Chang YL; Pan SH; Wang WL; Hong TM; Yang PC
Cancer Res; 2013 Jul; 73(13):4009-19. PubMed ID: 23698466
[TBL] [Abstract][Full Text] [Related]
37. Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation.
Li MY; Lai PL; Chou YT; Chi AP; Mi YZ; Khoo KH; Chang GD; Wu CW; Meng TC; Chen GC
Oncogene; 2015 Jul; 34(29):3791-803. PubMed ID: 25263444
[TBL] [Abstract][Full Text] [Related]
38. HGF-independent potentiation of EGFR action by c-Met.
Dulak AM; Gubish CT; Stabile LP; Henry C; Siegfried JM
Oncogene; 2011 Aug; 30(33):3625-35. PubMed ID: 21423210
[TBL] [Abstract][Full Text] [Related]
39. The linoleic acid metabolite, (13S)-hydroperoxyoctadecadienoic acid, augments the epidermal growth factor receptor signaling pathway by attenuation of receptor dephosphorylation. Differential response in Syrian hamster embryo tumor suppressor phenotypes.
Glasgow WC; Hui R; Everhart AL; Jayawickreme SP; Angerman-Stewart J; Han BB; Eling TE
J Biol Chem; 1997 Aug; 272(31):19269-76. PubMed ID: 9235921
[TBL] [Abstract][Full Text] [Related]
40. Regulation of EGFR trafficking and cell signaling by Sprouty2 and MIG6 in lung cancer cells.
Walsh AM; Lazzara MJ
J Cell Sci; 2013 Oct; 126(Pt 19):4339-48. PubMed ID: 23868981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
